Prostate radiotherapy in patients with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis of randomised controlled trials

Introduction: The incidence of synchronous metastatic hormone-sensitive prostate cancer (mHSPC) is rising with the increasing use of next-generation imaging. Local radiotherapy (RT) was shown to improve survival in patients with mHSPC; however, new data require a re-assessment of the indication and...

Full description

Bibliographic Details

Published in:	Clinical and Translational Radiation Oncology
Main Authors:	Navid Roessler, Marcin Miszczyk, Alessandro Dematteis, Fabio Zattoni, Tamás Fazekas, Filippo Carletti, Giuseppe Reitano, Akihiro Matsukawa, Ahmed R. Alfarhan, Angelo Cormio, Abdulrahman S. Alqahtani, Timo F.W. Soeterik, Giulia Marvaso, Giorgio Gandaglia, Péter Nyirády, Paweł Rajwa, Łukasz Nyk, Peter Soo Palencia, Michael S. Leapman, Barbara A. Jereczek-Fossa, Shahrokh F. Shariat
Format:	Article
Language:	English
Published:	Elsevier 2025-09-01
Subjects:	Radiotherapy Local treatment Metastatic hormone sensitive prostate cancer Overall survival Adverse events Primary tumor/prostate/local treatment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405630825001016